Education
About Us
Working with TipRanks
Follow Us
CNO Financial (CNO)
NYSE:CNO
Top Page
CNO Financial
(NYSE:CNO)
Select Model
Select Model
Rating:72Outperform
Price Target:
$44.00
▲(11.39% Upside)
CNO Financial's overall score reflects strong earnings growth and strategic initiatives, particularly in the Consumer and Worksite divisions. While financial performance shows resilience, challenges in profit margins and cash flow management are noted. The technical outlook is neutral, and valuation metrics suggest a fair market price.
CNO Financial (CNO) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$4.15B
Dividend Yield1.54%
Average Volume (3M)553.14K
Price to Earnings (P/E)15.2
Beta (1Y)0.69
Revenue Growth-1.61%
EPS Growth15.79%
CountryUS
Employees3,400
SectorN/A
Sector StrengthN/A
IndustryInsurance - Life
Share Statistics
EPS (TTM)1.29
Shares Outstanding95,353,516
10 Day Avg. Volume651,938
30 Day Avg. Volume553,136
Financial Highlights & Ratios
PEG Ratio0.17
Price to Book (P/B)1.58
Price to Sales (P/S)0.89
P/FCF Ratio6.29
Enterprise Value/Market Cap1.91
Enterprise Value/Revenue1.79
Enterprise Value/Gross Profit4.44
Enterprise Value/Ebitda8.50
Forecast
1Y Price Target
$40.00Price Target Upside1.27% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
CNO Financial Business Overview & Revenue Model
Company DescriptionCNO Financial Group, Inc. is a financial services holding company specializing in the insurance and financial services sectors. The company primarily serves middle-income working Americans, providing a range of products including life insurance, health insurance, annuities, and retirement solutions. CNO operates through several brands, including Colonial Penn, Bankers Life, and Washington National, catering to the unique financial needs of its customers across various stages of life.
How the Company Makes MoneyCNO Financial generates revenue through multiple streams, primarily through the sale of insurance products and services. The company's key revenue sources include premiums collected from life and health insurance policies, which provide a steady income stream. Additionally, CNO earns revenue from investment income generated by managing the premiums it receives before claims are paid out. Annuity sales also contribute to its revenue, as the company offers various annuity products that yield returns over time. Partnerships with agents and brokers enhance distribution, enabling CNO to reach a broader market and increase sales. Furthermore, CNO's focus on middle-income Americans positions it uniquely in a niche market, allowing for sustained growth and profitability.
CNO Financial Earnings Call Summary
Earnings Call Date:Nov 03, 2025
(Q3-2025)
| % Change Since: |
Next Earnings Date:Feb 10, 2026
Earnings Call Sentiment Positive
CNO Financial Group delivered a strong quarter with significant growth in new annualized premiums and operating earnings per share. The Consumer and Worksite divisions achieved record sales growth. However, challenges included the exit from the Worksite fee services business with associated impairment charges and a decline in Medicare Advantage sales.Q3-2025 Updates
Positive Updates
Strong Quarterly Performance
CNO Financial Group delivered a strong quarter with record total new annualized premiums of $125 million, up 26%. Operating earnings per diluted share were $1.29, up 16%.
Record Sales Growth in Consumer Division
The Consumer Division delivered its 12th consecutive quarter of sustained growth. Total Life insurance sales were up 33%, and record direct-to-consumer life insurance sales increased by 56%.
Worksite Division Insurance Sales
Worksite Life and Health NAP was up 20%, marking the seventh consecutive quarter of record NAP growth. Strategic growth initiatives contributed significantly, with a 42% increase in NAP growth.
Continued Growth in Annuities and Advisory
Annuity collected premiums were up 2%, marking the ninth consecutive quarter of growth. Client assets in brokerage and advisory were up 28%, surpassing $5 billion.
New Bermuda Treaty
CNO Financial executed a second Bermuda treaty, ceding approximately $1.8 billion of Supplemental Health U.S. statutory reserves, contributing to an expected 50 basis point improvement in operating ROE through 2027.
Negative Updates
Exit from Worksite Fee Services Business
CNO decided to exit the Worksite fee services business, which contributed a pretax annual loss of approximately $20 million. This decision followed years of underperformance and increased competition.
Impairment Charges
CNO recorded a $96.7 million impairment in non-operating income on the goodwill and intangibles associated with the acquisitions of Web Benefit Design and DirectPath.
Challenges in Medicare Advantage Sales
Medicare Advantage policies sold were down 24%, reflecting a shift in consumer preferences from Medicare Advantage to Medicare Supplement plans.
Company Guidance
During the CNO Financial Group's Third Quarter 2025 Earnings Call, several key metrics and strategic moves were highlighted. The company reported record total new annualized premiums of $125 million, marking a 26% increase and sustaining double-digit insurance sales growth across both divisions. Operating earnings per diluted share rose by 16% to $1.29. CNO also returned $76 million to shareholders in the quarter and $310 million year-to-date, while the book value per diluted share, excluding AOCI, was $38.10, up 6%. The company announced a second Bermuda treaty and changes to its Worksite Division's fee services business, aiming for a 50 basis point improvement in operating ROE through 2027. The growth scorecard metrics were predominantly positive, with particular strength in the Consumer Division, which saw Life and Health New Annualized Premiums (NAP) rise by 27% and direct-to-consumer life insurance sales increase by 56%. Meanwhile, the Worksite Division delivered a seventh consecutive quarter of record NAP growth at 20%, with highlights including significant growth in life, hospital indemnity, critical illness, and accident insurance. Additionally, CNO's annuity collected premiums grew 2%, maintaining a nine-quarter growth streak, with client assets in brokerage and advisory soaring 28%, surpassing $5 billion.CNO Financial Financial Statement Overview
Summary
Income Statement
75
Positive
Balance Sheet
68
Positive
Cash Flow
70
Positive
| Breakdown |
|---|
Income Statement |
| Total Revenue |
| Gross Profit |
| EBITDA |
| Net Income |
Balance Sheet |
| Total Assets |
| Cash, Cash Equivalents and Short-Term Investments |
| Total Debt |
| Total Liabilities |
| Stockholders Equity |
Cash Flow |
| Free Cash Flow |
| Operating Cash Flow |
| Investing Cash Flow |
| Financing Cash Flow |
CNO Financial Technical Analysis
Positive
39.50
Price Trends
40.42
Positive
39.47
Positive
38.71
Positive
Market Momentum
0.77
Negative
73.39
Negative
92.96
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CNO, the sentiment is Positive. The current price of 39.5 is below the 20-day moving average (MA) of 41.16, below the 50-day MA of 40.42, and above the 200-day MA of 38.71, indicating a bullish trend. The MACD of 0.77 indicates Negative momentum. The RSI at 73.39 is Negative, neither overbought nor oversold. The STOCH value of 92.96 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for CNO.
CNO Financial Peers Comparison
UnderperformOutperform
Sector (―)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| ― | ― | ― | ― | ― | ― | ― | |
77 Outperform | $4.19B | 9.30 | 10.12% | 2.92% | -4.58% | ― | |
74 Outperform | $3.71B | 4.43 | 16.27% | ― | 27.71% | ― | |
73 Outperform | $7.32B | 14.90 | 5.50% | 2.97% | 24.94% | ― | |
72 Outperform | $4.15B | 15.23 | 11.12% | 1.54% | -1.61% | 15.79% | |
71 Outperform | $8.78B | 4.15 | 21.66% | 3.90% | 35.76% | 636.97% | |
60 Neutral | $3.66B | 17.36 | 2.86% | ― | 1.41% | 150.35% |
* Sector Average
CNO
CNO Financial
43.55
7.21
19.84%
GNW
Genworth Financial
9.17
2.19
31.38%
LNC
Lincoln National
46.21
16.52
55.64%
BHF
Brighthouse Financial
64.91
16.84
35.03%
JXN
Jackson Financial Incorporation
107.69
21.72
25.26%
FG
F&G Annuities & Life Inc
31.15
-9.37
-23.12%
CNO Financial Corporate Events
Business Operations and Strategy
CNO Financial Highlights Strategic Focus in New Briefing
Positive
Sep 10, 2025
On September 10, 2025, CNO Financial Group issued a Consumer Division Briefing presentation, highlighting its strategic focus on middle-income households and its commitment to growth through multiple distribution channels. The briefing emphasized CNO’s differentiated ‘health and wealth’ approach, its strong market positioning, and consistent growth, with a notable increase in Medicare Advantage sales and a growing distribution force. The company aims to continue building enduring value for stakeholders and addressing the needs of an underserved market.
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.